Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancer. [electronic resource] by
- Chen, Zhongqing
- Ding, Weihong
- Xu, Ke
- Tan, Jun
- Sun, Chuanyu
- Gou, Yuancheng
- Tong, Shijun
- Xia, Guowei
- Fang, Zujun
- Ding, Qiang
Producer: 20130409
In:
PloS one vol. 7
Availability: No items available.
|
|
16.
|
The preclinical assessment of XL388, a mTOR kinase inhibitor, as a promising anti-renal cell carcinoma agent. [electronic resource] by
- Xiong, Zuquan
- Zang, Yiwen
- Zhong, Shan
- Zou, Lujia
- Wu, Yishuo
- Liu, Shenghua
- Fang, Zujun
- Shen, Zhoujun
- Ding, Qiang
- Chen, Shanwen
Producer: 20180305
In:
Oncotarget vol. 8
Availability: No items available.
|
|
17.
|
Mesenchymal stem cells in prostate cancer have higher expressions of SDF-1, CXCR4 and VEGF. [electronic resource] by
- Ding, Guanxiong
- Wang, Lujia
- Xu, Hua
- Xu, Zheng
- Feng, Chenchen
- Ding, Qiang
- Fang, Zujun
- Wu, Zhong
- Jiang, Haowen
- Xu, Jianfeng
- Gao, Peng
Producer: 20130808
In:
General physiology and biophysics vol. 32
Availability: No items available.
|
|
18.
|
RNA sequencing reveals upregulation of RUNX1-RUNX1T1 gene signatures in clear cell renal cell carcinoma. [electronic resource] by
- Xiong, Zuquan
- Yu, Hongjie
- Ding, Yan
- Feng, Chenchen
- Wei, Hanming
- Tao, Sha
- Huang, Dan
- Zheng, Siqun Lilly
- Sun, Jielin
- Xu, Jianfeng
- Fang, Zujun
Producer: 20150107
In:
BioMed research international vol. 2014
Availability: No items available.
|
|
19.
|
Genetic Analysis of Mismatch Repair Genes Alterations in Extramammary Paget Disease. [electronic resource] by
- Kang, Zhihua
- Xu, Feng
- Zhu, Yingfeng
- Fu, Pan
- Zhang, Qiao-An
- Hu, Tingting
- Li, Xiangyu
- Zhang, Qunfeng
- Wu, Zhiyuan
- Zhang, Xinju
- Wang, Hua
- Xu, Jinhua
- Fang, Zujun
- Guan, Ming
Producer: 20170719
In:
The American journal of surgical pathology vol. 40
Availability: No items available.
|
|
20.
|
Results of a randomized, double-blind, active-controlled clinical trial with propiverine extended release 30 mg in patients with overactive bladder. [electronic resource] by
- Leng, Jing
- Liao, Limin
- Wan, Ben
- Du, Chuanjun
- Li, Wei
- Xie, Keji
- Shen, Zhoujun
- Xu, Zhuoqun
- Wu, Shiliang
- Fang, Zujun
- Ma, Lulin
- Han, Shaomei
- Feustel, Cornelia
- Yang, Yong
- Madersbacher, Helmut
Producer: 20170524
In:
BJU international vol. 119
Availability: No items available.
|